Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways Diseases

NCT04765722 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT04765722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04765722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways Diseases
Lead sponsor
McMaster University
Phase
Phase 4
Overall status
Completed
Start date
December 14, 2021
Completion date
November 12, 2024
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, chronic cough, eosinophilic bronchitis